speb/financial-data huggingface dataset:
AGNCP balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 8010000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 643000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 58000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 58000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 309000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Income: 806000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 764000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 806000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 806000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 806000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 806000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 806000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Net Interest Income: 148000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -5551000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -3000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -3000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10918000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Normalized Income: 806000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 153000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 117000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Operating Revenue: 836000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1072700000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -389000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 10000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Other Payable: 1225000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1502000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Payables: 1395000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1395000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 81300000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 1968000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 42000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 1968000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Pretax Income: 806000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -22008000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Receivables: 1502000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -9038000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Salaries And Wages: 20000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 16457000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 20000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Share Issued: 1072700000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 9000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11444000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 8950000000.00
AGNCP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AGNCP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
AGNCP balance_sheet (quarterly, 2025-09-30) — Total Assets: 108969000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11502000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Total Debt: 58000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11444000000.00
AGNCP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 97525000000.00
AGNCP cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -805000000.00
AGNCP income_statement (annual, 2025-12-31) — +Total Revenue: 1797000000.00
AGNCP income_statement (quarterly, 2025-12-31) — +Total Revenue: 995000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 19261000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 19261000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 7405000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 7405000000.00
AGNCP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1771000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1911000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Capital Stock: 1979000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1979000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 450000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 450000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 18357000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 18357000000.00
AGNCP cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1601000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -428000000.00
AGNCP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 25182000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11059000000.00
AGNCP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -25864000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11356000000.00
AGNCP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 653000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 128000000.00
AGNCP cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -151000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -69000000.00
AGNCP cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 53000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -32000000.00
AGNCP cash_flow (annual, 2025-12-31) — Change In Working Capital: -98000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -101000000.00
AGNCP cash_flow (annual, 2025-12-31) — Changes In Cash: -29000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Changes In Cash: -169000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Common Stock: 11000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Common Stock: 11000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 10425000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10425000000.00
AGNCP cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1973000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 356000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 6000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 6000000.00
AGNCP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1509000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 908000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Dividends Payable: 182000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 182000000.00
AGNCP cash_flow (annual, 2025-12-31) — End Cash Position: 1742000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — End Cash Position: 1742000000.00
AGNCP cash_flow (annual, 2025-12-31) — Financing Cash Flow: 25182000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 11059000000.00
AGNCP cash_flow (annual, 2025-12-31) — Free Cash Flow: 653000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 128000000.00
AGNCP cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 529000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 26000000.00
AGNCP income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1122000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 789000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -323000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -323000000.00
AGNCP income_statement (annual, 2025-12-31) — General And Administrative Expense: 87000000.00
AGNCP income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 30000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Goodwill: 526000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Goodwill: 526000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCP income_statement (annual, 2025-12-31) — Interest Expense: 2848000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Interest Expense: 738000000.00
AGNCP income_statement (annual, 2025-12-31) — Interest Income: 3523000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Interest Income: 944000000.00
AGNCP cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 2793000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Invested Capital: 10481000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 10481000000.00
AGNCP cash_flow (annual, 2025-12-31) — Investing Cash Flow: -25864000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11356000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Investments And Advances: 7405000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 7405000000.00
AGNCP cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2307000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 356000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Long Term Debt: 56000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 56000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 56000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 56000000.00
AGNCP cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -12000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3000000.00
AGNCP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1973000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 356000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Income: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Income: 954000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1509000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 908000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 954000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 954000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 954000000.00
AGNCP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1670000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 954000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 954000000.00
AGNCP income_statement (annual, 2025-12-31) — Net Interest Income: 675000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Net Interest Income: 206000000.00
AGNCP cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -27271000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -16341000000.00
AGNCP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -12000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3000000.00
AGNCP cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -12000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3000000.00
AGNCP cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 334000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
AGNCP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 11867000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 11867000000.00
AGNCP income_statement (annual, 2025-12-31) — Normalized Income: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Normalized Income: 954000000.00
AGNCP cash_flow (annual, 2025-12-31) — Operating Cash Flow: 653000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 128000000.00
AGNCP cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1611000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -314000000.00
AGNCP income_statement (annual, 2025-12-31) — Operating Revenue: 1797000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Operating Revenue: 995000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1107600000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1107600000.00
AGNCP balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -323000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -323000000.00
AGNCP income_statement (annual, 2025-12-31) — Other Non Interest Expense: 40000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 11000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Other Payable: 193000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Other Payable: 193000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Other Receivables: 152000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 152000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Payables: 375000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Payables: 375000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 375000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 375000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 81300000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 81300000.00
AGNCP balance_sheet (annual, 2025-12-31) — Preferred Stock: 1968000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1968000000.00
AGNCP income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 161000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 46000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1968000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1968000000.00
AGNCP cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 334000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
AGNCP income_statement (annual, 2025-12-31) — Pretax Income: 1670000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Pretax Income: 954000000.00
AGNCP cash_flow (annual, 2025-12-31) — Purchase Of Investment: -98496000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -35800000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Receivables: 152000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Receivables: 152000000.00
AGNCP cash_flow (annual, 2025-12-31) — Repayment Of Debt: -12000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Retained Earnings: -8524000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -8524000000.00
AGNCP income_statement (annual, 2025-12-31) — Salaries And Wages: 87000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Salaries And Wages: 30000000.00
AGNCP cash_flow (annual, 2025-12-31) — Sale Of Investment: 71225000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 19459000000.00
AGNCP income_statement (annual, 2025-12-31) — Selling General And Administration: 87000000.00
AGNCP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 30000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Share Issued: 1107600000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Share Issued: 1107600000.00
AGNCP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 26000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 13000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 12393000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 12393000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 9899000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 9899000000.00
AGNCP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
AGNCP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
AGNCP balance_sheet (annual, 2025-12-31) — Total Assets: 115077000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Total Assets: 115077000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Total Capitalization: 12449000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 12449000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Total Debt: 56000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Total Debt: 56000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 12393000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 12393000000.00
AGNCP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 102684000000.00
AGNCP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 102684000000.00
AGNCP cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -2733000000.00
AGNCP cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -475000000.00
AGNCP income_statement (quarterly, 2026-03-31) — +Total Revenue: -114000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 19656000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 7485000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1742000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1979000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 493000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 20001000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -451000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2223000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1995000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 387000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 23000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 33000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 56000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Changes In Cash: 615000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Common Stock: 11000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10213000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 401000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 440000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -192000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 182000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — End Cash Position: 2357000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2223000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 387000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -74000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -433000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -331000000.00
AGNCP income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 23000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Goodwill: 526000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Interest Expense: 731000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Interest Income: 1050000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1995000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 7485000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 401000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -57000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 401000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Income: -148000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -192000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -148000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -148000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -148000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -148000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -148000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Net Interest Income: 319000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1127000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -57000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -57000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 11655000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Normalized Income: -148000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 387000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -456000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Operating Revenue: -114000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1147800000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -331000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 11000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Other Payable: 933000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Payables: 1115000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1115000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 81300000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1968000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 44000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1968000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Pretax Income: -148000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -44707000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Receivables: 0.00
AGNCP cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -57000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -9123000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Salaries And Wages: 23000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 43580000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Selling General And Administration: 23000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Share Issued: 1147800000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: -6000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12181000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 9687000000.00
AGNCP income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AGNCP income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Total Assets: 118897000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12181000000.00
AGNCP balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 106716000000.00
AGNCP cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 889000000.00
AGNCZ balance_sheet (annual, 2021-12-31) — Accounts Payable: 400000000.00
AGNCZ cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: -17000000.00
AGNCZ cash_flow (annual, 2021-12-31) — Common Stock Payments: -281000000.00
AGNCZ cash_flow (annual, 2021-12-31) — Preferred Stock Payments: 0.00
AGNCZ cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -281000000.00
AGNCZ income_statement (annual, 2022-12-31) — +Total Revenue: -1116000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 14186000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 3677000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1525000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Capital Stock: 1640000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1018000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 8956000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -869000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -11392000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 11188000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1013000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 38000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 69000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Change In Working Capital: 107000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Changes In Cash: 809000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Common Stock: 6000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6236000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Common Stock Issuance: 526000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Common Stock Payments: -51000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 99000000.00
AGNCZ income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1295000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Dividends Payable: 100000000.00
AGNCZ cash_flow (annual, 2022-12-31) — End Cash Position: 2334000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Financing Cash Flow: -11392000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Free Cash Flow: 1013000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 2916000000.00
AGNCZ income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2081000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -672000000.00
AGNCZ income_statement (annual, 2022-12-31) — General And Administrative Expense: 41000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Goodwill: 526000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCZ income_statement (annual, 2022-12-31) — Interest Expense: 625000000.00
AGNCZ income_statement (annual, 2022-12-31) — Interest Income: 1590000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 557000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Invested Capital: 6331000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Investing Cash Flow: 11188000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Investments And Advances: 3677000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 671000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Long Term Debt: 95000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 95000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -24000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 475000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Income: -1190000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -1295000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -1190000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -1190000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -1190000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -1190000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -1190000000.00
AGNCZ income_statement (annual, 2022-12-31) — Net Interest Income: 965000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 7187000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -24000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -24000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 145000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7344000000.00
AGNCZ income_statement (annual, 2022-12-31) — Normalized Income: -1190000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1013000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1714000000.00
AGNCZ income_statement (annual, 2022-12-31) — Operating Revenue: -1116000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 574600000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -672000000.00
AGNCZ income_statement (annual, 2022-12-31) — Other Non Interest Expense: 33000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Other Payable: 302000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Other Receivables: 120000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Payables: 402000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 402000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 67500000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Preferred Stock: 1634000000.00
AGNCZ income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 105000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 1634000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 145000000.00
AGNCZ income_statement (annual, 2022-12-31) — Pretax Income: -1190000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Purchase Of Investment: -55509000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Receivables: 120000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Repayment Of Debt: -24000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -51000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Retained Earnings: -7284000000.00
AGNCZ income_statement (annual, 2022-12-31) — Salaries And Wages: 41000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Sale Of Investment: 62696000000.00
AGNCZ income_statement (annual, 2022-12-31) — Selling General And Administration: 41000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Share Issued: 574600000.00
AGNCZ cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7870000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Tangible Book Value: 5710000000.00
AGNCZ income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCZ income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
AGNCZ balance_sheet (annual, 2022-12-31) — Total Assets: 51748000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Total Capitalization: 7965000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Total Debt: 95000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7870000000.00
AGNCZ balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 43878000000.00
AGNCZ cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 3795000000.00
AGNCZ income_statement (annual, 2023-12-31) — +Total Revenue: 251000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 15281000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 4242000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Beginning Cash Position: 2334000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Capital Stock: 1641000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 518000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 13389000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1005000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 14227000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -14672000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -118000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -892000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 904000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Change In Working Capital: 12000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Changes In Cash: -563000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Common Stock: 7000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6623000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1085000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
AGNCZ balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 362000000.00
AGNCZ income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 32000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Dividends Payable: 115000000.00
AGNCZ cash_flow (annual, 2023-12-31) — End Cash Position: 1771000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Financing Cash Flow: 14227000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Free Cash Flow: -118000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 1567000000.00
AGNCZ income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 497000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -517000000.00
AGNCZ income_statement (annual, 2023-12-31) — General And Administrative Expense: 62000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Goodwill: 526000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCZ income_statement (annual, 2023-12-31) — Interest Expense: 2287000000.00
AGNCZ income_statement (annual, 2023-12-31) — Interest Income: 2041000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2246000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Invested Capital: 6703000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Investing Cash Flow: -14672000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Investments And Advances: 4242000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1085000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Long Term Debt: 80000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 80000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -17000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 1085000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Income: 155000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 32000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 155000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 155000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 155000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 155000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 155000000.00
AGNCZ income_statement (annual, 2023-12-31) — Net Interest Income: -246000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -10162000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -17000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -17000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
AGNCZ balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 7731000000.00
AGNCZ income_statement (annual, 2023-12-31) — Normalized Income: 155000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Operating Cash Flow: -118000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1181000000.00
AGNCZ income_statement (annual, 2023-12-31) — Operating Revenue: 251000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 694300000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -517000000.00
AGNCZ income_statement (annual, 2023-12-31) — Other Non Interest Expense: 34000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Other Payable: 210000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Payables: 325000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 325000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 54500000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Preferred Stock: 1634000000.00
AGNCZ income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 123000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 1634000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
AGNCZ income_statement (annual, 2023-12-31) — Pretax Income: 155000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Purchase Of Investment: -63115000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Receivables: 0.00
AGNCZ cash_flow (annual, 2023-12-31) — Repayment Of Debt: -17000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
AGNCZ balance_sheet (annual, 2023-12-31) — Retained Earnings: -8148000000.00
AGNCZ income_statement (annual, 2023-12-31) — Salaries And Wages: 62000000.00
AGNCZ cash_flow (annual, 2023-12-31) — Sale Of Investment: 52953000000.00
AGNCZ income_statement (annual, 2023-12-31) — Selling General And Administration: 62000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Share Issued: 694300000.00
AGNCZ cash_flow (annual, 2023-12-31) — Stock Based Compensation: 11000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Stockholders Equity: 8257000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Tangible Book Value: 6097000000.00
AGNCZ income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
AGNCZ income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
AGNCZ balance_sheet (annual, 2023-12-31) — Total Assets: 71596000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Total Capitalization: 8337000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Total Debt: 80000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 8257000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 63339000000.00
AGNCZ balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
AGNCZ cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -1678000000.00
AGNCZ balance_sheet (quarterly, 2024-09-30) — Other Receivables: 1706000000.00
AGNCZ income_statement (annual, 2024-12-31) — +Total Revenue: 973000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 17264000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 5577000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1771000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Capital Stock: 1643000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 505000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 18908000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1241000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 11083000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -11169000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 86000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 738000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -701000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Change In Working Capital: 37000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Changes In Cash: 0.00
AGNCZ balance_sheet (annual, 2024-12-31) — Common Stock: 9000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Common Stock Equity: 8128000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1967000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
AGNCZ balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 94000000.00
AGNCZ income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 731000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Dividends Payable: 143000000.00
AGNCZ cash_flow (annual, 2024-12-31) — End Cash Position: 1771000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Financing Cash Flow: 11083000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Free Cash Flow: 86000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 188000000.00
AGNCZ income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 955000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -591000000.00
AGNCZ income_statement (annual, 2024-12-31) — General And Administrative Expense: 74000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Goodwill: 526000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 526000000.00
AGNCZ income_statement (annual, 2024-12-31) — Interest Expense: 2931000000.00
AGNCZ income_statement (annual, 2024-12-31) — Interest Income: 2949000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2899000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Invested Capital: 8192000000.00
AGNCZ balance_sheet (quarterly, 2024-12-31) — Invested Capital: 8192000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Investing Cash Flow: -11169000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Investments And Advances: 5577000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1967000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Long Term Debt: 64000000.00
AGNCZ balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 64000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 64000000.00
AGNCZ balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 64000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -15000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1967000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Income: 863000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 731000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 863000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 863000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 863000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 863000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 863000000.00
AGNCZ income_statement (annual, 2024-12-31) — Net Interest Income: 18000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -6376000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -15000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -15000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
AGNCZ balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 9236000000.00
AGNCZ income_statement (annual, 2024-12-31) — Normalized Income: 863000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Operating Cash Flow: 86000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1840000000.00
AGNCZ income_statement (annual, 2024-12-31) — Operating Revenue: 973000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 897400000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -591000000.00
AGNCZ income_statement (annual, 2024-12-31) — Other Non Interest Expense: 36000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Other Payable: 74000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Payables: 217000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 217000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 44500000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Preferred Stock: 1634000000.00
AGNCZ income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 132000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 1634000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
AGNCZ income_statement (annual, 2024-12-31) — Pretax Income: 863000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Purchase Of Investment: -60844000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Receivables: 0.00
AGNCZ cash_flow (annual, 2024-12-31) — Repayment Of Debt: -15000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
AGNCZ balance_sheet (annual, 2024-12-31) — Retained Earnings: -8554000000.00
AGNCZ income_statement (annual, 2024-12-31) — Salaries And Wages: 74000000.00
AGNCZ cash_flow (annual, 2024-12-31) — Sale Of Investment: 54468000000.00
AGNCZ income_statement (annual, 2024-12-31) — Selling General And Administration: 74000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Share Issued: 897400000.00
AGNCZ cash_flow (annual, 2024-12-31) — Stock Based Compensation: 18000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Stockholders Equity: 9762000000.00
AGNCZ balance_sheet (annual, 2024-12-31) — Tangible Book Value: 7602000000.00